AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,507,000 | +13.9% | 5,000,000 | 0.0% | 0.03% | +3.6% |
| Q2 2020 | $3,956,000 | +2.2% | 5,000,000 | 0.0% | 0.03% | -6.7% |
| Q1 2020 | $3,870,000 | -6.0% | 5,000,000 | 0.0% | 0.03% | +50.0% |
| Q4 2019 | $4,118,000 | -0.8% | 5,000,000 | 0.0% | 0.02% | -13.0% |
| Q3 2019 | $4,150,000 | +3.5% | 5,000,000 | 0.0% | 0.02% | +4.5% |
| Q2 2019 | $4,009,000 | -53.9% | 5,000,000 | -50.0% | 0.02% | -59.3% |
| Q1 2019 | $8,691,000 | -5.5% | 10,000,000 | 0.0% | 0.05% | -11.5% |
| Q4 2018 | $9,198,000 | -12.4% | 10,000,000 | 0.0% | 0.06% | +5.2% |
| Q3 2018 | $10,499,000 | +2.2% | 10,000,000 | 0.0% | 0.06% | -7.9% |
| Q2 2018 | $10,270,000 | -1.6% | 10,000,000 | 0.0% | 0.06% | -7.4% |
| Q1 2018 | $10,437,000 | +20.5% | 10,000,000 | 0.0% | 0.07% | +54.5% |
| Q4 2017 | $8,658,000 | -10.8% | 10,000,000 | 0.0% | 0.04% | -41.3% |
| Q3 2017 | $9,704,000 | +0.8% | 10,000,000 | 0.0% | 0.08% | +5.6% |
| Q2 2017 | $9,629,000 | – | 10,000,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 25,985,000 | $23,462,000 | 12.71% |
| ANGELO GORDON & CO., L.P. | 39,070,000 | $38,738,000 | 4.35% |
| Context Partners Fund, L.P. | 14,068,000 | $12,630,000 | 2.74% |
| Context Capital Management, LLC | 14,068,000 | $12,630,000 | 2.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 48,555,000 | $43,700,000 | 2.36% |
| UBS OCONNOR LLC | 41,000,000 | $36,888,000,000 | 0.94% |
| WHITEBOX ADVISORS LLC | 12,518,000 | $11,239,000 | 0.47% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,780,000 | $23,198,000 | 0.21% |
| AQR Arbitrage LLC | 6,100,000 | $5,522,000 | 0.20% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,350,000 | $4,843,000 | 0.10% |